SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
176it's also likely that the potential partners on Femprox did not want to giveeico20-10/21/2014
175Good points MI and E. Lets see what the new business Dev guy does with Femprox markkind-10/21/2014
174well said MI, the FDA and EMA have given Femprox a clear PH3 regulatory pathway eico20110/21/2014
173Something tells me that further review of the China studies don't inspire muMirror Image110/21/2014
172Something tells me that further review of the China studies don't inspire mumarkkind-10/21/2014
171Spent some time looking at the new site and i don't like that femprox has diphoenix_rising-10/21/2014
170I was very surprised when I received word of the new deal, it wasn't expectephoenix_rising-10/21/2014
169My mantra has long been that US investors are US centric. So I totally agree thmokelumne river-10/20/2014
168Interesting day. I like the increased APRI exposure in the US market. Thank goodStrong Long-10/20/2014
167One of the things I like about the SI message board platform is that it allows rmokelumne river-10/20/2014
166very good points MI, the big money for PH3 of rayva and fispemiphene are a ways eico20-10/20/2014
165Red ? 2 weeks ago it was at 1.12, I don't see that as red really, with certaeico20-10/20/2014
164This Deal certainly is dilution to us - the existing shareholders - and it couldMirror Image110/20/2014
163Red ???? I think the market smells dilution alsomarkkind-10/20/2014
162yes, it's going to take time and lots of capital, But if Vitaros, Femprox aeico20-10/20/2014
161agree on all DG, I think it will be very interesting with Fispemifene, Androal ieico20-10/20/2014
160New Drug. isn't this expansion stuff what Dr D tried to do and got run out omarkkind-10/20/2014
159Well, that was an all around impressive performance early this morning. I wouldmokelumne river-10/20/2014
158Pascoe has done a good promo video interview available on the company site. Hopephoenix_rising-10/20/2014
157More on new drug apricusbio.com money.cnn.comphoenix_rising-10/20/2014
156Apricus has aquired a new drug nasdaq.comphoenix_rising-10/20/2014
155Thanks Eman, hoping for encouraging news there. Still feel good about the futureStrong Long-10/19/2014
154yahoo.com 5 Alternatives to Viagra Worth Tryingeico20-10/19/2014
153that article on Yahoo really gives some excellent insight, sex is more complicateico20-10/19/2014
152looking at the studies , how well it works depends on the severity of the diseaseico20-10/19/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News